ClinicalTrials.gg
CompletedNCT07826013Updated Sep 22, 2026

The Effect of Horticultural Therapy on Anxiety and Quality of Life

An interventional study of Horticultural Therapy Practice Group in Horticultural Therapy, sponsored by Hasan Kalyoncu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-22.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Hasan Kalyoncu University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Mar 2025, registered Sep 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The purpose of the study is to examine the effects of a horticultural therapy program on anxiety levels in older adults and to evaluate the impact of this therapy on quality of life. The study was conducted as a randomized controlled experimental study using a pre-test-post-test design.

Research Hypotheses Hypothesis 1: Horticultural therapy reduces anxiety levels in older adults. Hypothesis 2: Horticultural therapy improves the overall quality of life in older adults.

Read the detailed description

Participants in the intervention and control groups were administered a pretest consisting of the Demographic Information Form, the World Health Organization Quality of Life Scale-Brief Form (WHOQOL-BREF), and the Geriatric Anxiety Scale. In the study, older adults in the intervention group participated in gardening activities once a week on Wednesdays throughout the week, under the guidance of an expert academic in the field. No intervention was applied to the control group, which continued with its routine activities. In accordance with the horticultural therapy protocol, academic support and guidance were sought from Prof. Dr. Hakan Yıldırım, Dean of the Faculty of Agriculture, regarding the organization and preparation of the planting area and the implementation of gardening activities for the intervention group. In this study, the horticultural therapy program was implemented not as a psychotherapeutic intervention but as a non-pharmacological nursing intervention based on the literature, involving structured plant planting, care, and gardening activities.

02

Conditions studied

  • Horticultural Therapy

Browse trials for

Keywords

  • Older Adults
  • Anxiety
  • Quality of Life
03

In context

Anxiety Disorders Unverified

7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 56 is below the median of 80 across 6,062 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Hasan Kalyoncu University is the lead sponsor of 166 studies on the registry; 33 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteer to participate in horticultural therapy activities.

Exclusion criteria

Exclusion Criteria:

  • People with an acute illness or a severe physical disability.
  • Those who are reluctant to participate in horticultural therapy.
  • Individuals who are unable to participate regularly in the program.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Horticultural Therapy Practice Group

    In the study, the older adults in the intervention group participated in gardening activities once a week on Wednesdays for 12 weeks, under the guidance of an academic expert in the field.

    Behavioral: Horticultural Therapy Practice Group

  • No intervention
    Control group

    No intervention was performed on the control group, which continued its routine activities.

Interventions

  • BehavioralHorticultural Therapy Practice Group

    The Effect of Horticultural Therapy on Anxiety and Quality of Life in Older Adults

06

What researchers measure

Primary outcomes

  1. Geriatric Anxiety Scale (GAS)

    A 30-item self-report scale developed to assess symptoms of anxiety in older adults, comprising somatic, cognitive, and affective subdimensions.Although there is no reverse scoring on the scale, each item is scored on a scale from 0 to 3. The items on the scale are scored on a 4-point Likert scale as "Never (0)," "Sometimes (1)," "Most of the time (2)," and "Always (3)." Somatic (physical) subscale-1, 6, 7, 15, 19, 20, 21 (9 items); Cognitive Subscale-2, 3, 10, 14, 16, 17, 22, 23 (8 items); Mood Subscale-4, 5, 8, 9, 11, 12, 13, 18 (8 items). For the total score, only the scores of the first 23 items are summed; the scale ranges from a low score of 0 to a high score of 69. According to the scale results, a high score indicates a high level of anxiety.

    Time frame: Week 0

  2. Geriatric Anxiety Scale (GAS)

    A 30-item self-report scale developed to assess symptoms of anxiety in older adults, comprising somatic, cognitive, and affective subdimensions.Although there is no reverse scoring on the scale, each item is scored on a scale from 0 to 3. The items on the scale are scored on a 4-point Likert scale as "Never (0)," "Sometimes (1)," "Most of the time (2)," and "Always (3)." Somatic (physical) subscale-1, 6, 7, 15, 19, 20, 21 (9 items); Cognitive Subscale-2, 3, 10, 14, 16, 17, 22, 23 (8 items); Mood Subscale-4, 5, 8, 9, 11, 12, 13, 18 (8 items). For the total score, only the scores of the first 23 items are summed; the scale ranges from a low score of 0 to a high score of 69. According to the scale results, a high score indicates a high level of anxiety.

    Time frame: Week 12

  3. World Health Organization Quality of Life Scale Short Form-Turkish Version (WHOQOL-BREF-TR)

    Developed by the World Health Organization, this scale is a comprehensive measure that assesses the well-being of older adults and enables cross-cultural comparisons. The WHOQOL-BREF scale consists of a total of 26 questions, including two questions-one regarding overall perceived quality of life and the other regarding perceived health status-and is composed of four main domains: physical, psychological, social relationships, and environmental. While the scale does not have an overall total score, each section and domain is scored on a scale of up to 20 points or 100 points.

    Time frame: Week 0

  4. World Health Organization Quality of Life Scale Short Form-Turkish Version (WHOQOL-BREF-TR)

    Developed by the World Health Organization, this scale is a comprehensive measure that assesses the well-being of older adults and enables cross-cultural comparisons. The WHOQOL-BREF scale consists of a total of 26 questions, including two questions-one regarding overall perceived quality of life and the other regarding perceived health status-and is composed of four main domains: physical, psychological, social relationships, and environmental. While the scale does not have an overall total score, each section and domain is scored on a scale of up to 20 points or 100 points.

    Time frame: Week 12

07

Study locations

1 site
  • Hasan Kalyoncu Universty
    Gaziantep, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Aug 2025, 5 months.

Of 3,841 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 5 months is below that.

Counting every sponsor, half of 3,943 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2026
First posted
Sep 17, 2026
StartActual
Mar 1, 2025
Primary completionActual
Aug 30, 2025
CompletionActual
Aug 30, 2025
Last update
Sep 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07826013
Responsible party
Demet Ünlü (Registered Nurse, Hasan Kalyoncu University) — Principal investigator
First posted
Sep 17, 2026
Start date
Mar 1, 2025
Primary completion
Aug 30, 2025
Completion
Aug 30, 2025
Last update
Sep 22, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion